Synthetic Siglec-9 agonists inhibit neutrophil activation associated with COVID-19

Mostrar otras versiones (1)

Severe cases of coronavirus disease 2019 (COVID-19), caused by infection with SARS-CoV-2, are characterized by a hyperinflammatory immune response that leads to numerous complications. Production of proinflammatory neutrophil extracellular traps (NETs) has been suggested to be a key factor in induci...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaveris, Corleone S., Wilk, Aaron J., Riley, Nicholas M., Stark, Jessica C., Yang, Samuel S., Rogers, Angela J., Ranganath, Thanmayi, Nadeau, Kari C., Blish, Catherine A., Bertozzi, Carolyn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ChemRxiv 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814829/
https://www.ncbi.nlm.nih.gov/pubmed/33469569
http://dx.doi.org/10.26434/chemrxiv.13378148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814829/
https://www.ncbi.nlm.nih.gov/pubmed/33469569
http://dx.doi.org/10.26434/chemrxiv.13378148

Ejemplares similares